The pharmacogenomics program at Children’s Minnesota is the only pediatric-focused program in the Upper Midwest and one of only a few pharmacogenomics programs in the country focused exclusively on children and adolescents. Two of the conditions most commonly referred to our pharmacogenomics program are cancer and mental health.
A Children’s Minnesota surgeon is part of a University of Minnesota-led research team recently awarded a $3.7 million grant to prepare for human clinical trials of artificial, bioengineered pediatric blood vessels that grow with a patient.
Congratulations to Teresa Herriage, DNP, APRN, CPHON, who has accepted the position of Vice Chair of the Children’s Oncology Group (COG) Nursing Discipline. COG is the world’s largest organization devoted exclusively to childhood and adolescent cancer research.
Children’s Minnesota’s innovative The Kid Experts™ At Home monitoring program is now available at all three of the organization’s Neonatal Intensive Care Unit locations.
A new study co-authored by Dr. Andrew Kiragu, critical care physician at Children’s Minnesota, reveals guns are now the leading cause of death among kids 0 to 19 years old in the United States.
The research found that Black children with Type 1 diabetes (T1D) were at a higher risk to be readmitted for diabetic ketoacidosis (DKA) compared to other racial groups, regardless of whether they lived in a high-opportunity or low-opportunity neighborhood.
Dr. Manu Madhok, trauma and emergency department physician at Children’s Minnesota, and his research team published a study that reveals non-White children experiencing cardiac arrest receive CPR from a bystander at a lower rate compared to White children.
A new study from the Centers for Disease Control and Prevention (CDC) confirmed the effectiveness of the Pfizer-BioNTech (mRNA) COVID-19 vaccine to protect non-immunocompromised kids between ages 5-17 from COVID-19-related hospitalizations, and Emergency Department and Urgent Care visits.
The Midwest Fetal Care Center (MWFCC), a collaboration between Children’s Minnesota and Allina Health, is participating in a large multicenter National Institutes of Health (NIH)-funded study targeting improved surveillance and care for pregnant women with anti-SSA/Ro antibodies who are at risk for fetal heart block.
Congratulations to Kelly Bergmann, DO, MS, director of research for the department of emergency medicine at Children’s Minnesota, for being awarded Best Overall Abstract in the Emergency Medicine section and the Advocacy Scholarship Recognition by the Emergency Medicine Advocacy Subcommittee at The American Academy of Pediatrics (AAP) 2021 Virtual National Conference & Exhibition.